Professionals and executives specializing in Rx-to-OTC switch, regulatory affairs, brand marketing, and medical affairs are all invited to attend DGE’s 3rd Rx-to-OTC Switch being held in Philadelphia February 26-27, 2024. This summit aims to educate switch teams to design strategies to guarantee a successful switch, analyze new regulations surrounding ACNU, discuss the impact of e-commerce on OTC products, and navigate potential marketing challenges between health care professionals and consumers.
This conference is hosted by Dynamic Global Events, a leading event company that organizes B2B conferences for healthcare organizations. This platform is a viable forum for education, discussion, and interaction among peers and many industry professionals. Global leaders and industry experts from Sanofi, Haleon, Bayer, Astrazeneca, and many other widely recognized companies will all be featured during this event.
In the past year, the life science industry has seen two important switches: Opill and Naloxone. These successful switches have increased accessibility to two very important medications. How will these open the pathway for new switches? Additionally, the recently introduced ACNU promises to enhance consumers access to nonprescription drugs by enabling switches through advanced digital methods. How will ACNU affect regulatory decisions and what implications could it have on the consumer?
In addition to recent regulatory changes, there has been an increase in digital technology surrounding the marketing and sale of OTC products. Industry leading speakers from Astrazeneca and BTG Pharmaceuticals will delve into the world of digital transformation and explore topics such as the impact of e-commerce on OTC products and the effect of social media on modern marketing strategies.
The 3rd Rx-To-OTC Switch will witness industry leading speakers share their thoughts and strategies on successful switches and demonstrate how to maintain profitability to minimize risk and maximize reward. Attendees will hear about case studies on recent switches, regulatory challenges concerning ACNU, latest digital developments, marketing strategies, and much more!
For more information, please visit https://nnw.fm/czdS7.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer
NetworkNewsWire5
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is powered by IBN
